The DOI matches its Crossref record; 79 of the 79 references it cites were found in a registry or an index.
Acute Myeloid Leukemia
Open accessAbstract
OverviewAcute myeloid leukemia (AML) is a heterogeneous hematologic malignancy characterized by the clonal expansion of myeloid blasts in the peripheral blood, bone marrow, and/or other tissues.It is the most common form of acute leukemia among adults and accounts for the largest number of annual deaths from leukemias in the United States.An estimated 13,780 people will be diagnosed with AML in 2012, and 10,200 patients will die of the disease. 1 The median age of diagnosis is 67 years, with 54% of patients diagnosed at 65 years or older (and approximately a third of these diagnosed at ≥ 75 years of age). 2 Thus, as the population ages, the incidence of AML, along with myelodysplasia, seems to be rising.Environmental factors that have long been established to in-NCCN
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Döhner, H., Estey, E. H., Amadori, S., Appelbaum, F. R., Büchner, T., Burnett, A. K., Dombret, H., Fenaux, P., Grimwade, D., Larson, R. A., et al. (2010) · Blood · doi:10.1182/blood-2009-07-235358 · Cited by 3,373
Self-citationWHO Classification: Tumours of the Haematopoietic and Lymphoid Tissues (2008)
(2015) · Postgraduate Haematology · doi:10.1002/9781118853771.ch51 · Cited by 3,290
Harris, N. L., Jaffe, E. S., Diebold, J., Flandrin, G., Muller-Hermelink, H. K., Vardiman, J., Lister, T. A., & Bloomfield, C. D. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.12.3835 · Cited by 3,267
Grimwade, D., Walker, H., Oliver, F., Wheatley, K., Harrison, C., Harrison, G., Rees, J., Hann, I., Stevens, R., Burnett, A., et al. (1998) · Blood · doi:10.1182/blood.v92.7.2322 · Cited by 2,655
Cheson, B. D., Bennett, J. M., Kopecky, K. J., Büchner, T., Willman, C. L., Estey, E. H., Schiffer, C. A., Doehner, H., Tallman, M. S., Lister, T. A., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.04.036 · Cited by 2,654
Self-citationRecurring mutations found by sequencing an acute myeloid leukemia genome
Mardis, E. R., Ding, L., Dooling, D. J., Larson, D. E., McLellan, M. D., Chen, K., Koboldt, D. C., Fulton, R. S., Delehaunty, K. D., McGrath, S. D., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0903840 · Cited by 2,219
Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
Patel, J. P., Gönen, M., Figueroa, M. E., Fernandez, H., Sun, Z., Racevskis, J., Van Vlierberghe, P., Dolgalev, I., Thomas, S., Aminova, O., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1112304 · Cited by 1,946
Self-citationCytoplasmic Nucleophosmin in Acute Myelogenous Leukemia with a Normal Karyotype
Falini, B., Mecucci, C., Tiacci, E., Alcalay, M., Rosati, R., Pasqualucci, L., La Starza, R., Diverio, D., Colombo, E., Santucci, A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa041974 · Cited by 1,892
Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia
Cornely, O. A., Maertens, J., Winston, D. J., Perfect, J., Ullmann, A. J., Walsh, T. J., Helfgott, D., Holowiecki, J., Stockelberg, D., Goh, Y.-T., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa061094 · Cited by 1,813
Mutations and Treatment Outcome in Cytogenetically Normal Acute Myeloid Leukemia
Schlenk, R. F., Döhner, K., Krauter, J., Fröhling, S., Corbacioglu, A., Bullinger, L., Habdank, M., Späth, D., Morgan, M., Benner, A., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa074306 · Cited by 1,628
Slovak, M. L., Kopecky, K. J., Cassileth, P. A., Harrington, D. H., Theil, K. S., Mohamed, A., Paietta, E., Willman, C. L., Head, D. R., Rowe, J. M., et al. (2000) · Blood · doi:10.1182/blood.v96.13.4075 · Cited by 1,601
Self-citationByrd, J. C. (2002) · Blood · doi:10.1182/blood-2002-03-0772 · Cited by 1,597
Kottaridis, P. D., Gale, R. E., Frew, M. E., Harrison, G., Langabeer, S. E., Belton, A. A., Walker, H., Wheatley, K., Bowen, D. T., Burnett, A. K., et al. (2001) · Blood · doi:10.1182/blood.v98.6.1752 · Cited by 1,551
Intensive Postremission Chemotherapy in Adults with Acute Myeloid Leukemia
Mayer, R. J., Davis, R. B., Schiffer, C. A., Berg, D. T., Powell, B. L., Schulman, P., Omura, G. A., Moore, J. O., McIntyre, O. R., & Frei, E. (1994) · New England Journal of Medicine · doi:10.1056/nejm199410063311402 · Cited by 1,427
Self-citationAge and acute myeloid leukemia
Appelbaum, F. R., Gundacker, H., Head, D. R., Slovak, M. L., Willman, C. L., Godwin, J. E., Anderson, J. E., & Petersdorf, S. H. (2006) · Blood · doi:10.1182/blood-2005-09-3724 · Cited by 1,350
Self-citationInternal tandem duplication of the flt3 gene found in acute myeloid leukemia.
Nakao, M., Yokota, S., Iwai, T., Kaneko, H., Horiike, S., Kashima, K., Sonoda, Y., Fujimoto, T., & Misawa, S. (1996) · PubMed · Cited by 1,162
Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies
Yamamoto, Y. (2001) · Blood · doi:10.1182/blood.v97.8.2434 · Cited by 1,150
Anthracycline Dose Intensification in Acute Myeloid Leukemia
Fernandez, H. F., Sun, Z., Yao, X., Litzow, M. R., Luger, S. M., Paietta, E. M., Racevskis, J., Dewald, G. W., Ketterling, R. P., Bennett, J. M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0904544 · Cited by 919
Self-citationFröhling, S., Schlenk, R. F., Breitruck, J., Benner, A., Kreitmeier, S., Tobis, K., Döhner, H., & Döhner, K. (2002) · Blood · doi:10.1182/blood-2002-05-1440 · Cited by 871
Döhner, K., Schlenk, R. F., Habdank, M., Scholl, C., Rücker, F. G., Corbacioglu, A., Bullinger, L., Fröhling, S., Döhner, H., & for the AML Study Group (AMLSG) (2005) · Blood · doi:10.1182/blood-2005-05-2164 · Cited by 849
Issa, J.-P. J., Garcia-Manero, G., Giles, F. J., Mannari, R., Thomas, D., Faderl, S., Bayar, E., Lyons, J., Rosenfeld, C. S., Cortes, J., et al. (2004) · Blood · doi:10.1182/blood-2003-03-0687 · Cited by 809
Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemia.
Kiyoi, H., Naoe, T., Nakano, Y., Yokota, S., Minami, S., Miyawaki, S., Asou, N., Kuriyama, K., Jinnai, I., Shimazaki, C., et al. (1999) · PubMed · doi:10.1182/blood.v93.9.3074 · Cited by 757
Thiede, C., Koch, S., Creutzig, E., Steudel, C., Illmer, T., Schaich, M., Ehninger, G., & (DSIL), F. T. D. S. L. (2006) · Blood · doi:10.1182/blood-2005-08-3167 · Cited by 736
Schnittger, S., Schoch, C., Kern, W., Mecucci, C., Tschulik, C., Martelli, M. F., Haferlach, T., Hiddemann, W., & Falini, B. (2005) · Blood · doi:10.1182/blood-2005-06-2248 · Cited by 713
Bloomfield, C. D., Lawrence, D. D., Byrd, J. C., Carroll, A. J., Pettenati, M. J., Tantravahi, R. V., Patil, S., Davey, F. R., Berg, D. T., Schiffer, C. A., et al. (1998) · PubMed · Cited by 682
Whitman, S. P., Archer, K. J., Lin, F., Baldus, C. D., Becknell, B., Carlson, B. D., Carroll, A. J., Mrózek, K., Vardiman, J., George, S. L., et al. (2001) · PubMed · Cited by 633
Verhaak, R. G. W., Goudswaard, C. S., van Putten, W., Bijl, M. A., Sanders, M. A., Hugens, W., Uitterlinden, A. G., Erpelinck, C. A. J., Delwel, R., Löwenberg, B., et al. (2005) · Blood · doi:10.1182/blood-2005-05-2168 · Cited by 618
Breems, D. A., Van Putten, W. L. J., De Greef, G. E., Van Zelderen-Bhola, S. L., Gerssen-Schoorl, K. B. J., Mellink, C. H. M., Nieuwint, A., Jotterand, M., Hagemeijer, A., Beverloo, H. B., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.0259 · Cited by 580
Falini, B., Nicoletti, I., Martelli, M. F., & Mecucci, C. (2007) · Blood · doi:10.1182/blood-2006-07-012252 · Cited by 565
Preudhomme, C., Sagot, C., Boissel, N., Cayuela, J.-M., Tigaud, I., de Botton, S., Thomas, X., Raffoux, E., Lamandin, C., Castaigne, S., et al. (2002) · Blood · doi:10.1182/blood-2002-03-0990 · Cited by 501
Kayser, S., Döhner, K., Krauter, J., Köhne, C.-H., Horst, H. A., Held, G., von Lilienfeld-Toal, M., Wilhelm, S., Kündgen, A., Götze, K., et al. (2011) · Blood · doi:10.1182/blood-2010-08-301713 · Cited by 487
Weick, J., Kopecky, K., Appelbaum, F., Head, D., Kingsbury, L., Balcerzak, S., Bickers, J., Hynes, H., Welborn, J., Simon, Sr., et al. (1996) · Blood · doi:10.1182/blood.v88.8.2841.bloodjournal8882841 · Cited by 411
Self-citationBacher, U., Haferlach, C., Kern, W., Haferlach, T., & Schnittger, S. (2008) · Blood · doi:10.1182/blood-2007-05-091215 · Cited by 411
Cytarabine Dose for Acute Myeloid Leukemia
Löwenberg, B., Pabst, T., Vellenga, E., van Putten, W., Schouten, H. C., Graux, C., Ferrant, A., Sonneveld, P., Biemond, B. J., Gratwohl, A., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1010222 · Cited by 407
Abbas, S., Lugthart, S., Kavelaars, F. G., Schelen, A., Koenders, J. E., Zeilemaker, A., van Putten, W. J. L., Rijneveld, A. W., Löwenberg, B., & Valk, P. J. M. (2010) · Blood · doi:10.1182/blood-2009-11-250878 · Cited by 393
Schnittger, S., Kohl, T. M., Haferlach, T., Kern, W., Hiddemann, W., Spiekermann, K., & Schoch, C. (2006) · Blood · doi:10.1182/blood-2005-04-1466 · Cited by 380
Cairoli, R. (2006) · Blood · doi:10.1182/blood-2005-09-3640 · Cited by 375
Boissel, N., Leroy, H., Brethon, B., Philippe, N., de Botton, S., Auvrignon, A., Raffoux, E., Leblanc, T., Thomas, X., Hermine, O., et al. (2006) · Leukemia · doi:10.1038/sj.leu.2404188 · Cited by 357
Suciu, S. (2003) · Blood · doi:10.1182/blood-2002-12-3714 · Cited by 347
Burnett, A. K., Wheatley, K., Goldstone, A. H., Stevens, R. F., Hann, I. M., Rees, J. H. K., Harrison, G., & the Medical Research Council Adult and Paediatric Working Parties (2002) · British Journal of Haematology · doi:10.1046/j.1365-2141.2002.03724.x · Cited by 339
Mead, A. J., Linch, D. C., Hills, R. K., Wheatley, K., Burnett, A. K., & Gale, R. E. (2007) · Blood · doi:10.1182/blood-2006-04-015826 · Cited by 327
Phase I Study of Decitabine Alone or in Combination With Valproic Acid in Acute Myeloid Leukemia
Blum, W., Klisovic, R. B., Hackanson, B., Liu, Z., Liu, S., Devine, H., Vukosavljevic, T., Huynh, L., Lozanski, G., Kefauver, C., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.4169 · Cited by 315
Self-citationGreen, C. L., Koo, K. K., Hills, R. K., Burnett, A. K., Linch, D. C., & Gale, R. E. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.2501 · Cited by 273
Mauritzson, N., Albin, M., Rylander, L., Billström, R., Ahlgren, T., Mikoczy, Z., Björk, J., Strömberg, U., Nilsson, P., Mitelman, F., et al. (2002) · Leukemia · doi:10.1038/sj.leu.2402713 · Cited by 269
Whitman, S. P., Ruppert, A. S., Radmacher, M. D., Mrózek, K., Paschka, P., Langer, C., Baldus, C. D., Wen, J., Racke, F., Powell, B. L., et al. (2008) · Blood · doi:10.1182/blood-2007-08-107946 · Cited by 266
Self-citationRöllig, C., Bornhäuser, M., Thiede, C., Taube, F., Kramer, M., Mohr, B., Aulitzky, W., Bodenstein, H., Tischler, H.-J., Stuhlmann, R., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.32.8500 · Cited by 265
Therapy-related leukemia and myelodysplasia: susceptibility and incidence
Leone, G., Pagano, L., Ben-Yehuda, D., & Voso, M. T. (2007) · Haematologica · doi:10.3324/haematol.11034 · Cited by 236
Risk Assessment in Patients with Acute Myeloid Leukemia and a Normal Karyotype
Bienz, M., Ludwig, M., Mueller, B. U., Oppliger Leibundgut, E., Ratschiller, D., Solenthaler, M., Fey, M. F., & Pabst, T. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1552 · Cited by 235
van Waalwijk van Doorn-Khosrovani, S. B., Erpelinck, C., Meijer, J., van Oosterhoud, S., van Putten, W. L. J., Valk, P. J. M., Berna Beverloo, H., Tenen, D. G., Löwenberg, B., & Delwel, R. (2003) · The Hematology Journal · doi:10.1038/sj.thj.6200216 · Cited by 235
Whitman, S. P., Maharry, K., Radmacher, M. D., Becker, H., Mrózek, K., Margeson, D., Holland, K. B., Wu, Y.-Z., Schwind, S., Metzeler, K. H., et al. (2010) · Blood · doi:10.1182/blood-2010-05-283648 · Cited by 225
Self-citationPautas, C., Merabet, F., Thomas, X., Raffoux, E., Gardin, C., Corm, S., Bourhis, J.-H., Reman, O., Turlure, P., Contentin, N., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.2652 · Cited by 218
Therapy-Related Acute Promyelocytic Leukemia
Beaumont, M., Sanz, M., Carli, P. M., Maloisel, F., Thomas, X., Detourmignies, L., Guerci, A., Gratecos, N., Rayon, C., San Miguel, J., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.09.072 · Cited by 215
Medeiros, B. C., Othus, M., Fang, M., Roulston, D., & Appelbaum, F. R. (2010) · Blood · doi:10.1182/blood-2010-02-270330 · Cited by 209
Self-citationChou, W.-C., Hou, H.-A., Chen, C.-Y., Tang, J.-L., Yao, M., Tsay, W., Ko, B.-S., Wu, S.-J., Huang, S.-Y., Hsu, S.-C., et al. (2010) · Blood · doi:10.1182/blood-2009-11-253070 · Cited by 204
Chou, W.-C., Lei, W.-C., Ko, B.-S., Hou, H.-A., Chen, C.-Y., Tang, J.-L., Yao, M., Tsay, W., Wu, S.-J., Huang, S.-Y., et al. (2011) · Leukemia · doi:10.1038/leu.2010.267 · Cited by 177
Parker, J. E., Pagliuca, A., Mijovic, A., Cullis, J. O., Czepulkowski, B., Rassam, S. M. B., Samaratunga, I. R., Grace, R., Gover, P. A., & Mufti, G. J. (1997) · British Journal of Haematology · doi:10.1046/j.1365-2141.1997.4763281.x · Cited by 163
Smith, M., Barnett, M., Bassan, R., Gatta, G., Tondini, C., & Kern, W. (2004) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2003.11.002 · Cited by 162
Wierzbowska, A., Robak, T., Pluta, A., Wawrzyniak, E., Cebula‐Obrzut, B., Hołowiecki, J., Kyrcz‐Krzemień, S., Grosicki, S., Giebel, S., Skotnicki, A. B., et al. (2007) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2007.00988.x · Cited by 141
Renneville, A., Boissel, N., Nibourel, O., Berthon, C., Hélevaut, N., Gardin, C., Cayuela, J., Hayette, S., Reman, O., Contentin, N., et al. (2012) · Leukemia · doi:10.1038/leu.2011.382 · Cited by 139
Fludarabine, cytarabine, and G-CSF (FLAG) for the treatment of poor risk acute myeloid leukemia
Montillo, M., Mirto, S., Petti, M. C., Latagliata, R., Magrin, S., Pinto, A., Zagonel, V., Mele, G., Tedeschi, A., & Ferrara, F. (1998) · American Journal of Hematology · Cited by 134
Farag, S. S., Maharry, K. S., Zhang, M., Pérez, W. S., George, S. L., Mrózek, K., DiPersio, J. F., Bunjes, D. W., Marcucci, G., Baer, M. R., et al. (2011) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2011.06.005 · Cited by 125
Self-citationLenz, G., Dreyling, M. H., Schiegnitz, E., Haferlach, T., Hasford, J., Unterhalt, M., & Hiddemann, W. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.06.016 · Cited by 125
DNMT3A Mutations in Acute Myeloid Leukemia
Ley, T. J., & on behalf of Genomics of AML Program Project Grant (2011) · Blood · doi:10.1182/blood.v118.21.sci-31.sci-31 · Cited by 119
Chotirat, S., Thongnoppakhun, W., Promsuwicha, O., Boonthimat, C., & Auewarakul, C. U. (2012) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-5-5 · Cited by 116
Al‐Ali, H. K., Jaekel, N., Junghanß, C., Maschmeyer, G., Krahl, R., Cross, M. A., Hoppe, G., & Niederwieser, D. W. (2011) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2011.606382 · Cited by 113
Carney, D. A., Westerman, D., Tam, C. S. L., Milner, A., Prince, H. M., Kenealy, M. K., Wolf, M., Januszewicz, E. H., Ritchie, D., Came, N. A., et al. (2010) · Leukemia · doi:10.1038/leu.2010.218 · Cited by 107
Pulsoni, A. (2002) · Blood · doi:10.1182/blood-2001-12-0312 · Cited by 102
Etiology and Management of Therapy-Related Myeloid Leukemia
Larson, R. A. (2007) · Hematology · doi:10.1182/asheducation-2007.1.453 · Cited by 95
Borthakur, G. M., Lin, E., Jain, N., Estey, E. E., Cortes, J. E., O'Brien, S. M., Faderl, S. H., Ravandi, F., Pierce, S. A., & Kantarjian, H. M. (2009) · Cancer · doi:10.1002/cncr.24367 · Cited by 86
Self-citationBecker, P. S., Kantarjian, H. M., Appelbaum, F. R., Petersdorf, S. H., Storer, B. E., Pierce, S. A., Shan, J., Hendrie, P. C., Pagel, J. M., Shustov, A. R., et al. (2011) · British Journal of Haematology · doi:10.1111/j.1365-2141.2011.08831.x · Cited by 85
Self-citationBorthakur, G. M., Kantarjian, H. M., Wang, X., Plunkett, W. K., Gandhi, V. V., Faderl, S. H., Garcia‐Manero, G., Ravandi, F., Pierce, S. A., & Estey, E. H. (2008) · Cancer · doi:10.1002/cncr.23927 · Cited by 81
Self-citationMartino, R., Valcárcel, D., Brunet, S., Sureda, A. M., & Sierra, J. (2007) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1705879 · Cited by 65
Pagano, L., Pulsoni, A., Tosti, M. E., Avvisati, G., Mele, L., Mele, A., Martino, B., Visani, G., Cerri, R., Bona, E. D., et al. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.02527.x · Cited by 65
Bishop, J. F., Matthews, J. P., Young, G. A. R., Bradstock, K. F., & Lowenthal, R. M. (1998) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428199809092687 · Cited by 59
Therapy-Related Myeloid Neoplasms
Czader, M., & Orazi, A. (2009) · American Journal of Clinical Pathology · doi:10.1309/ajcpd85mcohhcomq · Cited by 57
Arceci, R. J. (2012) · Yearbook of Oncology · doi:10.1016/j.yonc.2012.07.011 · Cited by 29
Incidence and Prognostic Influence of DNMT3A Mutations in Acute Myeloid Leukemia
Arceci, R. J. (2011) · Yearbook of Oncology · doi:10.1016/j.yonc.2011.08.004 · Cited by 29
van Doorn-Khosrovani, S. B. V. W., Erpelinck-Verschueren, C. A. J., Meijer, J. M., van Oosterhoud, S., van Putten, W. L. J., Valk, P. J. M., Beverloo, H. B., Tenen, D. G., Löwenberg, B., & Delwel, R. (2002) · The Hematology Journal · doi:10.1038/sj.thj.6200214 · Cited by 6
Renneville, A., Boissel, N., Nibourel, O., Berthon, C., Hélevaut, N., Gardin, C., Cayuela, J., Hayette, S., Reman, O., Contentin, N., et al. (2011) · Blood · doi:10.1182/blood.v118.21.2506.2506 · Cited by 4
Cited by
An update of current treatments for adult acute myeloid leukemia
Dombret, H., & Gardin, C. (2016) · Blood · doi:10.1182/blood-2015-08-604520 · Cited by 550
Lancet, J. E., Cortes, J. E., Hogge, D. E., Tallman, M. S., Kovacsovics, T. J., Damon, L. E., Komrokji, R., Solomon, S. R., Kolitz, J. E., Cooper, M., et al. (2014) · Blood · doi:10.1182/blood-2013-12-540971 · Cited by 339
Self-citationStein, E. M., DiNardo, C. D., Fathi, A. T., Pollyea, D. A., Stone, R. M., Altman, J. K., Roboz, G. J., Patel, M. R., Collins, R., Flinn, I. W., et al. (2019) · Blood · doi:10.1182/blood-2018-08-869008 · Cited by 331
Self-citationA distinct glucose metabolism signature of acute myeloid leukemia with prognostic value
Chen, W.-L., Wang, J.-H., Zhao, A.-H., Xu, X., Wang, Y.-H., Chen, T.-L., Li, J.-M., Mi, J.-Q., Zhu, Y.-M., Liu, Y.-F., et al. (2014) · Blood · doi:10.1182/blood-2014-02-554204 · Cited by 302
Li, L., Osdal, T., Ho, Y., Chun, S., McDonald, T., Agarwal, P., Lin, A., Chu, S., Qi, J., Li, L., et al. (2014) · Cell stem cell · doi:10.1016/j.stem.2014.08.001 · Cited by 234
Metadata
- Authors
- O'Donnell, M. R., Abboud, C. N., Altman, J., Appelbaum, F. R., Arber, D. A., Attar, E., Borate, U., Coutre, S. E., Damon, L. E., Goorha, S., Lancet, J., Maness, L. J., Marcucci, G., Millenson, M. M., Moore, J. O., Ravandi, F., Shami, P. J., Smith, B. D., Stone, R. M., Strickland, S. A., Tallman, M. S., Wang, E. S., Naganuma, M., & Gregory, K. M.
- Venue
- Journal of the National Comprehensive Cancer Network
- Publisher
- Harborside Press, LLC
- Published
- 2012-08
- Volume
- 10
- Issue
- 8
- Pages
- 984-1021
- ISSN
- 1540-1405 (ISSN-L)
- 1540-1413
- OpenAlex
- W2587631365
- Cited by
- 323
- References
- 79
- FWCI
- 21.90
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.